On April 14, 2024, at the Vietnam Opera House, Duoc Cuu Long proudly received the title of Top 10 Robustly Developing Enterprises of the year 2024.
The program was jointly conducted by the Institute of Economics and Culture in collaboration with the Consumer Protection Center to recognize and honor enterprises that have made significant contributions to the country’s economic development.
After several rounds of impartial evaluation and voting by the assessment council, DCL outstandingly earned the title of Top 10 Robustly Developing Enterprises of the year 2024. This marks a moment of immense pride as DCL triumphed in the most prestigious category for enterprises in Vietnam on its very first inclusion.
Mr. Nghiem Xuan Truong – Deputy General Director of DCL received the award for “Top 10 Robustly Developing Enterprises 2024”
In a market full of challenges and changes, DCL has remained steadfast in its goals for sustainable growth, investing in expanding production lines and building new factories to meet the increasingly high quality demands of the market. As a result, DCL continues to focus on the production and business of key products such as empty capsules, cancer drugs, medical supplies, etc.
According to the audited consolidated financial report of 2023, by the end of 2023, DCL’s total assets increased from 2,105 billion VND to over 2,277 billion VND; owner’s equity rose from over 1,391 billion VND to over 1,450 billion VND. These results reflect the efforts of the management team and all employees of DCL amidst the challenging economic conditions of 2023.
Currently, the company owns 04 factories, including 02 pharmaceutical plants meeting GMP-WHO standards and a 40ha medicinal herb farm in Binh Phuoc, 01 medical equipment manufacturing plant, and 01 Vicancap empty hard capsule manufacturing plant. This is the only unit in Vietnam that produces and supplies various types of capsules. The factories are currently operating at full capacity with advanced technology imported from Canada and South Korea.
With the goal of becoming the most highly regarded Vietnamese pharmaceutical company by patients, partners, and employees through innovative, accessible, and superior care products and services, DCL consistently invests heavily, continuously updating world-class technologies and applying them to production to offer high-quality products at reasonable prices.
In addition to investments in research and production, and ensuring the material and spiritual life of its employees, DCL also pays attention to creating value for the community. With a vision for sustainable development, promoting harmonious growth between the company and society, over the years, DCL has actively participated in community activities such as: donating gifts to support people in flood-affected Central regions; donating the Real-Time PCR automatic testing system to Vinh Long City Medical Center; sponsoring scientific and technical conferences of major hospitals to advance the national healthcare system, and more.
Being honored with the “Top 10 Robustly Developing Enterprises of the year 2024” is a well-deserved recognition, testament to DCL’s unceasing efforts in improving the quality of products and services, contributing to connecting and enhancing community life through optimal health solutions.
Previously, Duoc Cuu Long has also received many other prestigious awards such as: the Second-Class Labor Medal awarded by the President of the Socialist Republic of Vietnam in 2011; the Vietnamese Star Drug Award 2015; Top 10 famous brands and trademarks 2017, 2022, 2023;…
